Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets
about
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesThe Receptor-Binding Domain of Influenza Virus Hemagglutinin Produced in Escherichia coli Folds into Its Native, Immunogenic StructureA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 HemagglutininAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetHeterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralizationThe breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus.Refining the approach to vaccines against influenza A viruses with pandemic potential.Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineProperly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virusAntigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning.Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cellsScreening of random peptide library of hemagglutinin from pandemic 2009 A(H1N1) influenza virus reveals unexpected antigenically important regions.Influenza 2009 pandemic: Cellular immunemediated surveillance modulated by TH17 & Tregs.MF59 adjuvant: the best insurance against influenza strain diversity.MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccinesH5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.Antibodies against conserved antigens provide opportunities for reform in influenza vaccine designOligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.Detection of site-specific positive Darwinian selection on pandemic influenza A/H1N1 virus genome: integrative approaches.Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin.Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.Mapping antibody epitopes of the avian H5N1 influenza virusCharacterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes.Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferretIsolation of neurocysticercosis-related antigens from a genomic phage display library of Taenia solium.
P2860
Q24614628-C04AE554-6DBE-476C-9970-667F2A20C66EQ27665742-CE933A42-6F2D-4CA4-BC43-BE4D706A365CQ27679987-DEB5E51A-AEC3-4D1B-B79C-BB6BB0DC1191Q30227194-BF6EB4FA-7660-4E10-B2BB-063DA5AD6842Q30361644-1B588883-174E-4C4C-942F-B86E9F0A295FQ30365366-F4BB483E-062A-4D08-BB40-88DE254D6CDCQ30373175-98173736-B201-4CB5-8B14-CFDA8B8B7057Q30381595-AC33D0E7-56CA-461D-8706-073DFB51F8D7Q30387739-59092C80-1384-4557-99FB-FAAD58F49E06Q30388038-5A34EF01-148F-40C5-A5CA-C3B1C163F843Q30391443-C5E58E32-626B-48E5-8404-73144D05FE87Q30391721-CC08913A-5D0D-43D1-929E-7FF05C2C7422Q30393843-53521878-ABA9-4B94-B04E-97CC44910861Q30394097-8F779238-DFBE-43D8-8B07-3C0479EEF50BQ30396343-B206468A-7B7D-4815-A441-B3BBACBF6B5CQ30400550-0E49E8C6-1C17-421C-A202-77717567FEB5Q30401148-C689F949-A41F-4795-B78F-35C4467AC285Q30401513-9E7A495B-92FA-4FB7-9F09-F9934486F889Q30402018-13BCD629-0CFB-4447-B2F8-DD4992AFBE36Q30403361-9357E37B-2E5F-4615-8BCC-6EEB89EE1A9BQ30403507-53BD94E2-9B30-40B4-8BD5-D3E8FEE4E299Q30404218-4BB52374-B8D5-43A2-AFAD-0ECBAEEE1723Q30406365-0E36C4C9-B2AB-44E0-8FBE-0C6B43A248D5Q30407593-80C64CDD-F322-41EC-AFCA-1D0F7D6A0992Q30411189-C24EFD4C-18CF-4444-BCF4-6F40AD0C4B4BQ30411637-0E3E4215-BEE5-4B70-9907-DF09163BCB71Q30413677-49305FFF-7D74-4A48-9569-D77FE0754746Q30416502-3CCB4B83-A74C-4907-A6FA-DB9B8A094BCBQ30420990-6C2CFB26-A43A-4985-9173-9A507FC0DB05Q30421821-81871328-09C7-480D-BC56-F26809566508Q30424161-E772D0FF-459A-46D1-AF1B-CDC49800B3D5Q30427946-58F85F51-FC2D-4618-9A58-BAFD39844DBFQ30428745-EB459F12-F033-49AA-AF7C-C8DDE35F5BA8Q30913948-15C234C0-FE3A-4883-B008-76318F312604Q33350258-B6848CD1-F16F-45B7-B0A8-2DAA4FCBFD01Q33432749-AB2754C1-1EB2-4B29-A54F-1CBD70F4691CQ33494799-1D0E98DD-4EE8-41F1-B710-B7F9C3247B5AQ33530075-AA84BD5D-5FD9-4341-9E4B-D2E416A5D3BFQ33547457-65E0286C-C1CB-4BC2-834E-85812230CD46Q33727612-6A2C06F8-A000-49ED-977F-5533471E1EA0
P2860
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antigenic fingerprinting of H5 ...... vaccine and diagnostic targets
@ast
Antigenic fingerprinting of H5 ...... vaccine and diagnostic targets
@en
type
label
Antigenic fingerprinting of H5 ...... vaccine and diagnostic targets
@ast
Antigenic fingerprinting of H5 ...... vaccine and diagnostic targets
@en
prefLabel
Antigenic fingerprinting of H5 ...... vaccine and diagnostic targets
@ast
Antigenic fingerprinting of H5 ...... vaccine and diagnostic targets
@en
P2093
P2860
P50
P1433
P1476
Antigenic fingerprinting of H5 ...... vaccine and diagnostic targets
@en
P2093
Amorsolo L Suguitan
Hana Golding
Jody Manischewitz
Lisa R King
Surender Khurana
Yonaira Rivera
P2860
P304
P356
10.1371/JOURNAL.PMED.1000049
P407
P577
2009-04-21T00:00:00Z